Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations
Tanning beds triple melanoma risk, potentially causing broad DNA damage
Early relapse predicts poor outcomes in aggressive blood cancer
Study explores why some drug therapies are ineffective for brain tumour patients
New horizons in NSCLC targeted therapy: advancements and challenges
Chromatin accessibility maps reveal how stem cells drive myelodysplastic progression
Personalised cancer medicine: New insights into the benefits and risks of therapies
Proton therapy shows survival benefit in phase III trial for patients with head and neck cancers
Researchers find new way to deliver antibodies that could make treatment much easier for patients
SABCS 2025: Study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring treatment response in patients with bone metastases
Scientists uncover key driver of treatment-resistant cancer
Research strengthens evidence linking alcohol use to cancer